ABSTRACT
BACKGROUND: Feline injection site fibrosarcoma is an aggressive and infiltrative tumour arising in the background of chronic inflammation. The aim of this study was to evaluate the expression of metallothionein (I-II) in feline injection site fibrosarcomas and to assess its possible relationships with Ki67 index, inflammation score and tumour grade. The study included 40 feline fibrosarcomas, located in the common injection sites (i.e., interscapular area, thigh, flank), constituting archival diagnostic specimens collected between 2019-2020. Tumours were graded histologically according to the newly proposed soft-tissue sarcoma grading system in cats. Immunohistochemistry was performed to evaluate the expression of Ki67 and metallothionein in tumour cells. RESULTS: The cytoplasmic and sometimes nuclear expression of metallothionein was observed in all tumours grade I, 66.67% of tumours grade II and 55% of tumours grade III. The expression of metallothionein was negatively correlated with tumour grade and inflammation score, while the Ki67 index was positively correlated with tumour grade, inflammation score and necrosis score. CONCLUSION: The downregulation of MT expression in feline injection site fibrosarcomas seems to be connected with an increase in the inflammatory infiltration, hence tumour progression. This is the first study describing metallothionein expression in feline injection site fibrosarcomas.
Subject(s)
Cat Diseases , Fibrosarcoma , Injection Site Reaction , Metallothionein , Soft Tissue Neoplasms , Animals , Cats , Cat Diseases/physiopathology , Fibrosarcoma/physiopathology , Fibrosarcoma/veterinary , Ki-67 Antigen/metabolism , Metallothionein/genetics , Metallothionein/metabolism , Soft Tissue Neoplasms/physiopathology , Soft Tissue Neoplasms/veterinary , Down-Regulation , Injection Site Reaction/physiopathology , Injection Site Reaction/veterinaryABSTRACT
Doxorubicin (Dox) is one of the most used drugs in the treatment of Soft tissue sarcoma. However, acquired resistance linked with poor survival and numerous side effects are the major challenges. Meanwhile, miRNAs are reported to influence the chemotherapeutic responses. However, there is hardly any evidence on the involvement of tumor-suppressive miR-197 reported in our previous study in augmenting the sensitivity of fibrosarcoma cells to Dox. Therefore, in this study, we intend to decipher if miR-197-5p combined with Dox could increase the anticancer cytotoxicity. For this, we evaluated the antitumorigenic effects of Dox and miR-197-5p individually and in combination by performing a series of molecular assays. We noticed that the sub-lethal concentration of miR-197-5p markedly enhanced the sensitivity of HT1080 fibrosarcoma cells to Dox by promoting apoptosis and G2/M cell cycle arrest. We also observed miR-197-5p sensitizes HT1080 cells to Dox by increasing drug influx, possibly due to suppression of MDR genes (ABCC1, MVP). Moreover, we found that KIAA0101, a target of miR-197-5p is inhibited by Dox, which is further repressed when treated in combination with miRNA. We also observed a marked upregulation of p53, known to be negatively correlated with KIAA0101 in Dox and miR-197-5p combination treatment compared to Dox alone. Taken together, our study revealed that Dox chemotherapy in combination with miR-197-5p could overcome the problem of drug efflux and enhance its antitumor effects on fibrosarcoma.
Subject(s)
Doxorubicin/therapeutic use , Drug Resistance, Neoplasm , Fibrosarcoma/metabolism , MicroRNAs/metabolism , Multidrug Resistance-Associated Proteins/genetics , Antibiotics, Antineoplastic/metabolism , Antibiotics, Antineoplastic/therapeutic use , Apoptosis , Cell Line, Tumor , Doxorubicin/metabolism , Fibrosarcoma/drug therapy , Fibrosarcoma/genetics , Fibrosarcoma/physiopathology , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/physiology , Tumor Suppressor Protein p53/geneticsABSTRACT
In this era of precision medicine, numerous workflows for the targeting of high-recurrent mutations in common tumor types have been developed, leaving patients with rare diseases with few options. Here, we implement a functional precision oncology approach utilizing comprehensive genomic profiling in combination with high-throughput drug screening, to identify tumor-specific drug sensitivities for patients with rare tumor types such as myxofibrosarcoma. From a patient with a high-grade myxofibrosarcoma, who was enrolled in the Englander Institute for Precision Medicine (EIPM) program, we established patient-derived 3D sarco-spheres and xenograft models for functional testing. In the absence of a large cohort of clinically similar cases, high-throughput drug screening was performed on the patient-derived cells, and compared with two other myxofibrosarcoma lines and a benign fibroblast line to functionally identify tumor-specific drug sensitivities. The addition of functional drug sensitivity testing to complement genomic profiling identified multiple therapeutic options that were further validated in patient derived xenograft models. Genomic analyses detected the frequently known codeletion of the tumor suppressors CDKN2A/B together with the methylthioadenosine phosphorylase (MTAP) and a TP53 E286fs*50 mutation. High-throughput drug screening demonstrated tumor-specific sensitivity to compounds targeting the cell cycle. Based on genomic analysis and high-throughput drug screening, we show that targeting the cell cycle in these tumors is a powerful approach. IMPLICATIONS: This study demonstrates the potential of functional testing to aid clinical decision making for patients with rare or molecularly complex malignancies when combined with comprehensive genomic profiling.
Subject(s)
Biomarkers, Tumor/metabolism , Fibrosarcoma/physiopathology , High-Throughput Nucleotide Sequencing/methods , Medical Oncology/methods , Molecular Targeted Therapy/methods , Precision Medicine/methods , Animals , Female , Humans , Mice , Mice, Nude , MutationABSTRACT
Hyaluronan synthesis inhibitor 4-methylumbelliferone (4-MU) is a candidate of radiosensitizers which enables both anti-tumour and anti-metastasis effects in X-ray therapy. The curative effects under such 4-MU administration have been investigated in vitro; however, the radiosensitizing mechanisms remain unclear. Here, we investigated the radiosensitizing effects under 4-MU treatment from cell experiments and model estimations. We generated experimental surviving fractions of human fibrosarcoma cells (HT1080) after 4-MU treatment combined with X-ray irradiation. Meanwhilst, we also modelled the pharmacological effects of 4-MU treatment and theoretically analyzed the synergetic effects between 4-MU treatment and X-ray irradiation. The results show that the enhancement of cell killing by 4-MU treatment is the greatest in the intermediate dose range of around 4 Gy, which can be reproduced by considering intercellular communication (so called non-targeted effects) through the model analysis. As supposed to be the involvement of intercellular communication in radiosensitization, the oxidative stress level associated with reactive oxygen species (ROS), which leads to DNA damage induction, is significantly higher by the combination of 4-MU treatment and irradiation than only by X-ray irradiation, and the radiosensitization by 4-MU can be suppressed by the ROS inhibitors. These findings suggest that the synergetic effects between 4-MU treatment and irradiation are predominantly attributed to intercellular communication and provide more efficient tumour control than conventional X-ray therapy.
Subject(s)
Cell Communication/drug effects , Fibrosarcoma/pathology , Fibrosarcoma/physiopathology , Hymecromone/pharmacology , Radiation Tolerance/drug effects , Radiation-Sensitizing Agents , Cell Communication/radiation effects , Cell Line, Tumor , DNA Damage/drug effects , DNA Damage/radiation effects , Fibrosarcoma/drug therapy , Fibrosarcoma/radiotherapy , Humans , Hymecromone/therapeutic use , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Radiotherapy DosageABSTRACT
BACKGROUND/AIM: Myxofibrosarcoma (MFS) is characterized by an infiltrative growth pattern. This study aimed to determine the correlation between overall survival (OS) and morphological features of MFS as well as examine the reproducibility of these findings on preoperative magnetic resonance imaging (MRI). PATIENTS AND METHODS: Fifty-eight MFS patients underwent preoperative MR imaging with the following features analysed: i) tumour size, ii) localization, iii) margins, iv) morphology, v) signal characteristics, vi) contrast enhancement, vii) presence and extent of perilesional oedema, and viii) presence of the tail sign. RESULTS: Only circumscribed perilesional oedema was associated with a significantly better survival compared to diffuse oedema (p=0.010), which was found in the majority of cases. The tail sign was found in less than 50% of the cases. Cohen's kappa coefficients confirmed a relatively high interrater variability. CONCLUSION: Perilesional diffuse oedema on MR imaging of MFS is significantly correlated with a poor overall survival. The interrater variability in interpretation of MR examinations varies from slight to substantial agreement. Preoperative MR imaging with detailed planning of the resection seem to be a logical approach to achieve negative resection margins and recurrence-free survival.
Subject(s)
Fibrosarcoma/diagnostic imaging , Histiocytoma, Malignant Fibrous/diagnostic imaging , Neoplasm Recurrence, Local/diagnostic imaging , Soft Tissue Neoplasms/diagnostic imaging , Adult , Aged , Aged, 80 and over , Disease-Free Survival , Female , Fibrosarcoma/physiopathology , Histiocytoma, Malignant Fibrous/physiopathology , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Neoplasm Recurrence, Local/physiopathology , Preoperative Care , Prognosis , Soft Tissue Neoplasms/physiopathologySubject(s)
Fibroma , Fibrosarcoma , Kidney Neoplasms , Kidney , Liver Neoplasms , Neoplasm Recurrence, Local , Antineoplastic Agents/administration & dosage , Carboplatin/administration & dosage , Disease Progression , Doxorubicin/administration & dosage , Fibroma/pathology , Fibroma/physiopathology , Fibroma/surgery , Fibrosarcoma/pathology , Fibrosarcoma/physiopathology , Fibrosarcoma/surgery , Humans , Immunohistochemistry , Kidney/diagnostic imaging , Kidney/pathology , Kidney/surgery , Kidney Neoplasms/pathology , Kidney Neoplasms/physiopathology , Kidney Neoplasms/surgery , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Male , Middle Aged , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/drug therapy , Nephrectomy/methods , Tomography, X-Ray Computed/methodsABSTRACT
Infantile fibrosarcoma usually presents as a rapidly growing mass on the extremities or trunk. We describe spontaneous regression in a 5-month-old female infant with biopsy proven, molecularly confirmed, right leg infantile fibrosarcoma currently at 26 months of age with no signs of local recurrence. Previously reported cases of spontaneous regression are reviewed, suggesting a benign clinical course in some cases. Although evidence for spontaneous regression is anecdotal in this rare tumor type, physicians should weigh the risks and benefits of surgery and chemotherapy against watchful waiting.
Subject(s)
Fibrosarcoma/physiopathology , Remission, Spontaneous , Child, Preschool , Female , Fibrosarcoma/pathology , Humans , InfantABSTRACT
BACKGROUND: The cell-surface heparan sulfate proteoglycan syndecan-1 is important for tumor cell proliferation, migration, and cell cycle regulation in a broad spectrum of malignancies. Syndecan-1, however, also translocates to the cell nucleus, where it might regulate various molecular functions. RESULTS: We used a fibrosarcoma model to dissect the functions of syndecan-1 related to the nucleus and separate them from functions related to the cell-surface. Nuclear translocation of syndecan-1 hampered the proliferation of fibrosarcoma cells compared to the mutant lacking nuclear localization signal. The growth inhibitory effect of nuclear syndecan-1 was accompanied by significant accumulation of cells in the G0/G1 phase, which indicated a possible G1/S phase arrest. We implemented multiple, unsupervised global transcriptome and proteome profiling approaches and combined them with functional assays to disclose the molecular mechanisms that governed nuclear translocation and its related functions. We identified genes and pathways related to the nuclear compartment with network enrichment analysis of the transcriptome and proteome. The TGF-ß pathway was activated by nuclear syndecan-1, and three genes were significantly altered with the deletion of nuclear localization signal: EGR-1 (early growth response 1), NEK11 (never-in-mitosis gene a-related kinase 11), and DOCK8 (dedicator of cytokinesis 8). These candidate genes were coupled to growth and cell-cycle regulation. Nuclear translocation of syndecan-1 influenced the activity of several other transcription factors, including E2F, NFκß, and OCT-1. The transcripts and proteins affected by syndecan-1 showed a striking overlap in their corresponding biological processes. These processes were dominated by protein phosphorylation and post-translation modifications, indicative of alterations in intracellular signaling. In addition, we identified molecules involved in the known functions of syndecan-1, including extracellular matrix organization and transmembrane transport. CONCLUSION: Collectively, abrogation of nuclear translocation of syndecan-1 resulted in a set of changes clustering in distinct patterns, which highlighted the functional importance of nuclear syndecan-1 in hampering cell proliferation and the cell cycle. This study emphasizes the importance of the localization of syndecan-1 when considering its effects on tumor cell fate.
Subject(s)
Cell Cycle/genetics , Cell Nucleus/metabolism , Gene Regulatory Networks , Nuclear Localization Signals/genetics , Signal Transduction , Syndecan-1/metabolism , Apoptosis , Cell Line, Tumor , Cell Proliferation/genetics , Fibrosarcoma/genetics , Fibrosarcoma/physiopathology , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Gene Regulatory Networks/genetics , Gene Regulatory Networks/physiology , Humans , Nuclear Localization Signals/metabolism , Phosphorylation , Protein Processing, Post-Translational , Protein Transport/physiology , Proteome , Transcription Factors/genetics , Transcription Factors/metabolismABSTRACT
Metastasis is the primary cause of cancer death. The inflammatory tumor microenvironment contributes to metastasis, for instance, by recruiting blood and lymph vessels. Among tumor-infiltrating immune cells, tumor-associated macrophages (TAMs) take a center stage in promoting both tumor angiogenesis and metastatic spread. We found that genetic deletion of the S1P receptor 1 (S1pr1) alone in CD11bhi CD206+ TAMs infiltrating mouse breast tumors prevents pulmonary metastasis and tumor lymphangiogenesis. Reduced lymphangiogenesis was also observed in the nonrelated methylcholanthrene-induced fibrosarcoma model. Transcriptome analysis of isolated TAMs from both entities revealed reduced expression of the inflammasome component Nlrp3 in S1PR1-deficient TAMs. Macrophage-dependent lymphangiogenesis in vitro was triggered upon inflammasome activation and required both S1PR1 signaling and IL-1ß production. Finally, NLRP3 expression in tumor-infiltrating macrophages correlated with survival, lymph node invasion, and metastasis of mammary carcinoma patients. Conceptually, our study indicates an unappreciated role of the NLRP3 inflammasome in promoting metastasis via the lymphatics downstream of S1PR1 signaling in macrophages.
Subject(s)
Interleukin-1beta/physiology , Lymphangiogenesis/physiology , Macrophages/physiology , NLR Family, Pyrin Domain-Containing 3 Protein/physiology , Neoplasm Metastasis/physiopathology , Receptors, Lysosphingolipid/physiology , Animals , Breast Neoplasms/pathology , Breast Neoplasms/physiopathology , Female , Fibrosarcoma/physiopathology , Humans , Lymphatic Metastasis , Mammary Neoplasms, Experimental/physiopathology , Mice , Mice, Inbred C57BL , Sphingosine-1-Phosphate ReceptorsSubject(s)
Atrial Appendage , Cardiac Surgical Procedures , Fibrosarcoma , Heart Neoplasms , Adult , Atrial Appendage/diagnostic imaging , Atrial Appendage/pathology , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/methods , Echocardiography/methods , Fatal Outcome , Female , Fibrosarcoma/diagnostic imaging , Fibrosarcoma/pathology , Fibrosarcoma/physiopathology , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/pathology , Heart Neoplasms/physiopathology , Humans , Neoplasm Invasiveness , Tumor BurdenSubject(s)
Broad Ligament/pathology , Fibrosarcoma , Genital Neoplasms, Female , Hysterectomy/methods , Ovariectomy/methods , Adult , Antineoplastic Protocols , Chemoradiotherapy, Adjuvant/methods , Combined Modality Therapy/methods , Female , Fibrosarcoma/pathology , Fibrosarcoma/physiopathology , Fibrosarcoma/therapy , Genital Neoplasms, Female/pathology , Genital Neoplasms, Female/physiopathology , Genital Neoplasms, Female/therapy , Humans , Laparotomy/methods , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Staging , Pelvic Neoplasms/pathology , Pelvic Neoplasms/physiopathology , Pelvic Neoplasms/therapy , Treatment OutcomeABSTRACT
Fibroblast activation protein (FAP), an integral membrane serine protease, is found on fibro- and osteo-sarcoma and on myofibroblasts in epithelial carcinoma, but rarely on other adult tissue. FAP has been demonstrated to be an excellent target for tumor imaging in clinical trials, and antibodies and other FAP-targeting drugs are in development. Here we have shown that FAP overexpression increased the growth of HT1080 fibrosarcoma cells in vitro and in vivo, and found that the expression of FAP affects response to chemotherapy. When treated with doxorubicin, expression of FAP increased susceptibility to the drug. In spite of this, FAP-HT1080 cells had fewer markers of classical apoptosis than HT1080 cells and neither necrosis nor necroptosis were enhanced. However, levels of early mitochondrial and lysosomal membrane permeability markers were increased, and autophagy switched from a protective function in HT1080 cells to part of the cell death mechanism with FAP expression. Therefore, FAP may affect how the tumor responds to chemotherapeutic drugs overall, which should be considered in targeted drug development. The overexpression of FAP also alters cell signaling and responses to the environment in this cell line. This includes cell death mechanisms, changing the response of HT1080 cells to doxorubicin from classical apoptosis to an organelle membrane permeability-dependent form of cell death.
Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Fibrosarcoma/enzymology , Gelatinases/metabolism , Membrane Proteins/metabolism , Serine Endopeptidases/metabolism , Autophagy/drug effects , Cell Line, Tumor , Doxorubicin/pharmacology , Endopeptidases , Fibrosarcoma/drug therapy , Fibrosarcoma/genetics , Fibrosarcoma/physiopathology , Gelatinases/genetics , Humans , Membrane Proteins/genetics , Serine Endopeptidases/geneticsABSTRACT
While the parasympathetic nervous system appears to be involved in the regulation of tumor progression, its exact role is still unclear. Therefore, using a rat BP6-TU2 fibrosarcoma tumor model, we investigated the effect of (1) reduction of vagal activity produced by subdiaphragmatic vagotomy; and (2) enhancement of vagal activity produced by continuous delivery of electric impulses to the cervical part of the vagus nerve on tumor development and survival of tumor-bearing rats. We also evaluated the expression of cholinergic receptors within in vitro cultivated BP6-TU2 cells. Interestingly, we found that both, vagal stimulation and subdiaphragmatic vagotomy slightly reduced tumor incidence. However, survival of tumor-bearing rats was not affected by any of the experimental approaches. Additionally, we detected mRNA expression of the α1, α2, α5, α7, and α10 subunits of nicotinic receptors and the M1, M3, M4, and M5 subtypes of muscarinic receptors within in vitro cultivated BP6-TU2 cells. Our data indicate that the role of the vagus nerve in modulation of fibrosarcoma development is ambiguous and uncertain and requires further investigation.
Subject(s)
Fibrosarcoma/pathology , Vagus Nerve/physiopathology , Animals , Cell Line, Tumor , Electric Stimulation , Fibrosarcoma/mortality , Fibrosarcoma/physiopathology , Male , RNA, Messenger/metabolism , Rats, Wistar , Receptors, Muscarinic/genetics , Receptors, Muscarinic/metabolism , Receptors, Nicotinic/genetics , Receptors, Nicotinic/metabolism , Survival Rate , VagotomyABSTRACT
The geometric locations of ion traversals in mammalian cells constitute important information in the study of heavy ion-induced biological effect. Single ion traversal through a cellular nucleus produces complex and massive DNA damage at a nanometer level, leading to cell inactivation, mutations and transformation. We present a novel approach that uses a fluorescent nuclear track detector (FNTD) for the simultaneous detection of the geometrical images of ion traversals and DNA damage in single cells using confocal microscopy. HT1080 or HT1080-53BP1-GFP cells were cultured on the surface of a FNTD and exposed to 5.1-MeV/n neon ions. The positions of the ion traversals were obtained as fluorescent images of a FNTD. Localized DNA damage in cells was identified as fluorescent spots of γ-H2AX or 53BP1-GFP. These track images and images of damaged DNA were obtained in a short time using a confocal laser scanning microscope. The geometrical distribution of DNA damage indicated by fluorescent γ-H2AX spots in fixed cells or fluorescent 53BP1-GFP spots in living cells was found to correlate well with the distribution of the ion traversals. This method will be useful for evaluating the number of ion hits on individual cells, not only for micro-beam but also for random-beam experiments.
Subject(s)
DNA Damage/genetics , Fibrosarcoma/pathology , Fibrosarcoma/physiopathology , Microscopy, Confocal/instrumentation , Microscopy, Fluorescence/instrumentation , Radiometry/instrumentation , Cell Line, Tumor , Cell Survival/genetics , Cell Survival/radiation effects , Equipment Design , Equipment Failure Analysis , Humans , Ions , Linear Energy Transfer/radiation effects , Radiation Dosage , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
The exogenous administration of spermidine promotes longevity in many model organisms. It has been proposed that this anti-age activity of spermidine is related to this polyamine's ability to promote autophagy. Since spermidine is the substrate for the eIF5A post-translational modification by hypusination, we asked ourselves whether mature eIF5A may represent the link between spermidine and autophagy induction. To test this hypothesis, we inhibited the conversion of native eIF5A by a pharmacological approach, using the N1-guanyl-1,7-diamineoheptane (GC7), a spermidine analogue which competitively and reversibly inhibits deoxyhypusine synthase (DHS). In addition, we also employed genetic approaches by ablating both the eIF5A protein itself and DHS, the rate limiting enzyme catalyzing the conversion of lysine to hypusine. Collectively the data presented in this study demonstrate that the mature eIF5A (hypusinated form) is not involved in the autophagic pathway and that the inhibitor of DHS, GC7, produces off-target effect(s) resulting in marked induction of basal autophagy. These data are relevant in light of the fact that GC7 is considered a potent and selective inhibitor of DHS and is a potential candidate drug for cancer, diabetes and HIV therapy.
Subject(s)
Autophagy , Fibrosarcoma/physiopathology , Peptide Initiation Factors/metabolism , RNA-Binding Proteins/metabolism , Spermidine/metabolism , Cell Line, Tumor , Fibrosarcoma/enzymology , Fibrosarcoma/genetics , Humans , Lysine/analogs & derivatives , Lysine/metabolism , Oxidoreductases Acting on CH-NH Group Donors/genetics , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Peptide Initiation Factors/genetics , Protein Processing, Post-Translational , RNA-Binding Proteins/genetics , Spermidine/analogs & derivatives , Eukaryotic Translation Initiation Factor 5AABSTRACT
The Akt/mammalian target of rapamycin (mTOR) pathway plays important roles in modulating cellular function in response to extracellular signals such as growth factors and cytokines. The Akt/mTOR signaling pathway is activated in certain kinds of sarcomas. Myxofibrosarcoma is a soft tissue sarcoma, characterized by abundant myxoid stroma and frequent local recurrence. Here, we conducted a large-scale examination of the clinicopathological and activation statuses of the Akt/mTOR pathways in myxofibrosarcoma. The phosphorylation status of Akt, mTOR, S6 ribosomal protein, and the eukaryotic translation initiation factor 4E-binding protein, and mitogen-activated protein kinase were assessed by immunohistochemistry in 101 formalin-fixed, paraffin-embedded samples, including 68 primary tumors in myxofibrosarcoma. Immunohistochemical expressions were confirmed by Western blotting with 20 frozen samples, which were paired with normal tissue samples. PIK3CA and AKT1 gene mutations were also analyzed using 12 primary tumor frozen samples. Immunohistochemically, phosphorylations of Akt, mTOR, S6 ribosomal protein, 4E-binding protein, and mitogen-activated protein kinase 1/2 were observed in 64.7%, 45.6%, 42.6%, 63.2%, and 64.7% of samples. Phosphorylated Akt/mTOR pathway proteins were correlated with one another and were also correlated with the phosphorylation of these proteins in the concordant recurrent tumors. Immunoblotting showed a high degree of phosphorylation in tumor samples, compared with that in normal tissue samples. Activation of the Akt/mTOR pathway was correlated with histologic grade and tumor progression. Mutational analysis failed to reveal any PIK3CA or AKT1 mutations around the hot spots. Activation of the Akt/mTOR pathway was associated with histologic malignancy and tumor progression in primary and recurrent myxofibrosarcoma.
Subject(s)
Dermatofibrosarcoma/physiopathology , Fibrosarcoma/physiopathology , Histiocytoma, Malignant Fibrous/physiopathology , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/physiology , TOR Serine-Threonine Kinases/metabolism , Adult , Aged , Aged, 80 and over , Class I Phosphatidylinositol 3-Kinases , Dermatofibrosarcoma/pathology , Disease Progression , Female , Fibrosarcoma/pathology , Histiocytoma, Malignant Fibrous/pathology , Humans , Male , Middle Aged , Mitogen-Activated Protein Kinases/metabolism , Phosphatidylinositol 3-Kinases/genetics , Proto-Oncogene Proteins c-akt/genetics , Ribosomal Protein S6 Kinases, 70-kDa/metabolismABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Fibrosarcoma/complications , Fibrosarcoma/diagnosis , Breast Neoplasms/complications , Breast Neoplasms/diagnosis , Mammography/methods , Immunohistochemistry/methods , Immunohistochemistry , Liposarcoma, Myxoid/complications , Liposarcoma, Myxoid/diagnosis , Liposarcoma, Myxoid/surgery , Fibrosarcoma/physiopathology , Fibrosarcoma/surgery , Fibrosarcoma , Immunohistochemistry/standards , Mammography/instrumentation , Immunohistochemistry/trendsABSTRACT
Gallic acid and anthocyanins are abundant plant food bioactives present in many fruits and vegetables, being especially important in the composition of berries. Gallic acid has been shown to possess cytotoxic properties in several cancer cell lines and to inhibit carcinogenesis in animal models. However, its mechanism of action is not yet fully understood. The aim of this study was to elucidate whether the observed inhibitory activity of gallic acid against gelatinases corresponds to its cytotoxic activity in HT1080 cells and to determine if anthocyanins could exhibit a similar behavior. Gallic acid and delphinidin-3-glucoside have shown selective cytotoxicity towards HT1080 cells. Further analysis by a migration and invasion assay showed anti-invasive activities of gallic acid, delphinidin and pelargonidin-3-glucosides. Zymographic analysis demonstrated the inhibitory activity of gallic acid at the level of secreted and activated gelatinases. Moreover, gallic acid inhibited MMP-2 and MMP-9 proteolytic activity with very similar potency. NMR and molecular modelling experiments confirmed the interaction of gallic acid with MMP-2, and suggested that it takes place within the catalytic center. In this work we give some new experimental data supporting the role of these compounds in the inhibition of metalloproteases as the mechanism for their cytotoxic activity against fibrosarcoma.
Subject(s)
Anthocyanins/pharmacology , Antineoplastic Agents/pharmacology , Fibrosarcoma/drug therapy , Gallic Acid/pharmacology , Anthocyanins/chemistry , Antineoplastic Agents/chemistry , Binding Sites , Cell Line, Tumor , Cell Survival/drug effects , Dietary Supplements/analysis , Fibrosarcoma/enzymology , Fibrosarcoma/physiopathology , Gallic Acid/chemistry , Humans , Matrix Metalloproteinase 2/chemistry , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/chemistry , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase Inhibitors/chemistry , Matrix Metalloproteinase Inhibitors/pharmacology , Models, Biological , Models, MolecularABSTRACT
Neuronal activity in the nucleus of the solitary tract, ventrolateral medulla, area postrema, and parabrachial nucleus was studied in rats with intraperitoneal or subcutaneous tumors on the 7th, 14th, 21st, and 28th day after injection of fibrosarcoma tumor cells. We found that the number of Fos and dopamine ß-hydroxylase immunopositive neurons differs between animals with intraperitoneal and subcutaneous tumors and also between tumor-bearing rats at different times following injection. Our data indicate that responses of the brainstem structures to peripheral tumor growth depend on the localization as well as the stage of the tumor growth.
Subject(s)
Fibrosarcoma/physiopathology , Peritoneal Neoplasms/physiopathology , Rhombencephalon/physiopathology , Soft Tissue Neoplasms/physiopathology , Subcutaneous Tissue/physiopathology , Animals , Area Postrema/enzymology , Area Postrema/physiopathology , Biomarkers/metabolism , Dopamine beta-Hydroxylase/metabolism , Fibrosarcoma/pathology , Immunohistochemistry , Interleukin-1beta/blood , Male , Medulla Oblongata/enzymology , Medulla Oblongata/physiopathology , Neoplasm Transplantation , Peritoneal Neoplasms/pathology , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Wistar , Rhombencephalon/enzymology , Signal Transduction/physiology , Soft Tissue Neoplasms/pathology , Solitary Nucleus/enzymology , Solitary Nucleus/physiopathology , Subcutaneous Tissue/pathology , Time Factors , Tumor Burden , Tumor Necrosis Factor-alpha/bloodABSTRACT
We report a 43-year-old man with an implantable cardioverter defibrillator for aborted sudden cardiac death. He represents in extreme electrical storm with 111 different ventricular fibrillation episodes. Successful treatment was achieved with multiple antiarrhythmic agents, mechanical ventilation, external shocks, and ultimately overdrive pacing. A cardiac magnetic resonance scan revealed two cardiac lesions that were later diagnosed as metastatic fibrosarcoma. This case highlights two very important and increasingly common cardiological dilemmas: the management of extreme electrical storm and the role of magnetic resonance imaging in aborted cardiac death patients with an apparent "normal" heart.